Cancer

Despite past safety concerns, the antioxidant supplement beta-carotene, is safe to use during radiation therapy treatments for prostate cancer and does not increase the risk of prostate cancer death or metastases, according to a study in the May issue of the International Journal of Radiation Oncology*Biology*Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO).  

Use of the anti-diabetic agent pioglitazone (Actos) is associated with an increased risk of bladder cancer, a nested case-control study confirmed. Patients with type 2 diabetes who were ever treated with pioglitazone had an 83% higher risk for ...  

SALT LAKE CITY — Doctors with Intermountain Healthcare are countering national recommendations that say men should avoid a routine prostate-cancer screening test. The prostate-specific antigen test, which screens a man's blood for signs of cancer, came ...  

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/83g48s/triple_analysis_p) has announced the addition of the "Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Peptides" report to their offering. This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors...  

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/322rmn/triple_analysis_p) has announced the addition of the "Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Protein Kinase Inhibitors" report to their offering. This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase...  

Despite past safety concerns, the antioxidant supplement beta-carotene, is safe to use during radiation therapy treatments for prostate cancer and does not increase the risk of prostate cancer death or metastases, according to a study in the May issue of the International Journal of Radiation Oncology•Biology•Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO).  

Although some people may feel embarrassed about the idea of colorectal cancer screening and are worried about some of the procedures that are used, colorectal cancer screening decreases the risk of dying from colon cancer. So, it's important to push past ...  

Still, the overall risk of any one person developing bladder cancer by taking Actos is very small. "Patients with type 2 diabetes and their physicians need to be fully aware of the potential association between Actos and bladder cancer," says ...  

By the National Cancer Institute BETHESDA, Md., May 31, 2012 /PRNewswire-USNewswire/ -- Many people who fear cancer don't realize that some types of cancer are preventable. Cancer of the colon or rectum (together referred to as colorectal cancer) is one of these. What's more,...  

Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine ... received radiation treatment at a reduced dose of 23.4 Gy, according to Richard Curry, MD, of Memorial Sloan-Kettering Cancer Center in New York City, and colleagues.  

ViewRay has received FDA premarket notification clearance for its MRI-guided radiation therapy system. The ViewRay system features a unique combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI) for the treatment of cancer, providing continuous soft-tissue imaging during treatment so that clinicians can see and record precisely where radiation therapy is being delivered, as it is being delivered.Radiation...  

will be the keynote speaker Sunday at the Cancer Institute of New Jersey-Hamilton’s annual National Cancer Survivors’ Day. The free event will be held at 10 a.m. at the RWJ Hamilton Center for Health & Wellness on Quakerbridge Road and will include ...  

CHICAGO — Despite being at risk of cardiovascular problems associated with testicular cancer treatment ... of developing those late effects of treatment, according to a study from the Perelman School of Medicine at the University of Pennsylvania that ...  

[allAfrica.com] Nairobi, Kenya - At age 22, all Martha Achieng' Ooko really craved was freedom and a place to call her own. She was working hard as a beautician, giving manicures and pedicures in the western Kenyan city of Kisumu, saving to open her own salon one day. People who knew Ooko, the eldest of five children, believed she had what it takes to succeed.  

First they try to take away our mammograms, and now this? Last week, the U.S. Preventive Services Task Force (USPSTF) followed up their October 2011 draft guidelines to recommend, definitively, that doctors not offer routine Prostate-Specific Antigen (PSA ...  

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that it has opened enrollment for a Phase Ib clinical trial with the National Cancer Institutes Adult Brain Tumor Consortium (ABTC) using the companys first product candidate mibefradil. The trial will introduce a new...  

HOUSTON—There has been a lot of controversy lately about prostate cancer screenings. A government advisory panel recently recommended that doctors stop using the PSA test which screens healthy men for prostate cancer. June kicks off Men’s ...  

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Study at ASCO: TTF-1 does not correctly identify half of non-small cell lung carcinoma (NSCLC) cases in patients that present with metastatic or poorly differentiated cancer.  

PITTSBURGH--(BUSINESS WIRE)--Precision Therapeutics announces the acceptance of a new abstract on the ChemoFx in vitro drug response marker for publication in conjunction with the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting. The study, titled, In Vitro Chemoresponse Assay for Patients with Cervical Cancer, reports the results of ChemoFx testing in primary, metastatic or recurrent...  

Many people who fear cancer don't realize that some types of cancer are preventable. Cancer of the colon or rectum (together referred to as colorectal cancer) is one of these. What's more, colorectal cancer can often be treated effectively if it ...  

The Cancer Institute of New Jersey (CINJ) has been awarded renewal of its Comprehensive Cancer Center designation from the National Cancer Institute (NCI). This prestigious designation, presently awarded to only 41 such centers nationwide, is granted competitively to institutions characterized by the highest comprehensive scientific excellence in cancer research and the ability to bring research discoveries to patients. CINJ is the only NCI...  

Newswise — New Brunswick, N.J., May 31, 2012 – The Cancer Institute of New Jersey (CINJ) has been awarded renewal of its Comprehensive Cancer Center designation from the National Cancer Institute (NCI). This prestigious designation, presently awarded ...  

Researchers at Clarkson University, in collaboration with researchers from Columbia University, have found the binding partner of TDF, a pituitary hormone that had previously been shown to reduce cancer progression in breast cancer cells, in prostate cancer as well.  

[allAfrica.com] Nairobi, Kenya - At age 22, all Martha Achieng' Ooko really craved was freedom and a place to call her own. She was working hard as a beautician, giving manicures and pedicures in the western Kenyan city of Kisumu, saving to open her own salon one day. People who knew Ooko, the eldest of five children, believed she had what it takes to succeed.  

National Cancer Survivors Day(R), observed on June 3, 2012, celebrates the 12 million cancer survivors ... Take advantage of helpful resources. There are many free resources for people at every point of their cancer journey. A few of our favorites include ...  

Sci-Tech TodayPSA test is useful for careful doctorsPennLive.comWhen the US Preventive Services Task Force, a group of preventive medicine and primary care doctors, suggested last week that routine prostate screening not be done using the Prostate Specific Antigen test, they not only jeopardized an important tool, ...Doctors grapple with prostate cancer screening guidelinesBaltimore Sun (blog)Local doctor against dropping PSA test for prostate...  

Experts say adding chemo, radiation before surgery is now standard treatment for most with the disease Source: HealthDay Related MedlinePlus Pages: Cancer Chemotherapy, Esophageal Cancer, Radiation Therapy  

The new weapon in the battle against skin cancer is a very old weapon: Aspirin. People who take aspirin lower the risk of squamous cell carcinoma by 15%. The risk of malignant melanoma, the most life-threatening kind of skin cancer, is lower ...  

At the annual conference of the American Society of Clinical Oncology (ASCO), starting tomorrow in Chicago, drug giant Merck will be presenting no less than 100 abstracts detailing its efforts to develop new cancer drugs. The company’s oncology franchise head, Gary Gilliland—who left a 20-year faculty position at Harvard to join New Brunswick, NJ-based Merck [...]  

Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that it has opened enrollment for a Phase Ib clinical trial with the National Cancer Institute’s Adult Brain Tumor Consortium using the company’s first product candidate mibefradil.  

PITTSGROVE TWP. — South Jersey Healthcare will bring together cancer survivors and their families from the region to celebrate National Cancer Survivors Day on Sunday at picnic at Parvin State Park. The picnic will begin at noon and run ...  

including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS). The trial is being conducted at the MD Anderson Cancer Center. The drug’s safety profile ...  

Cabazitaxel (trade name: Jevtana®) has been approved since March 2011 in men with metastatic prostate cancer who no longer respond to conventional therapy with hormone blockers and have already been pre-treated with the cytostatic drug docetaxel. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether...  

La Peer Health Systems urologist, Dr. Premal J Desai, comments on the medical benefits and risks that may occur in PSA screening for men 75 years of age and older. Recently the United States Preventive Service Task Force (USPSTF) stated that the potential ...  

Prostate cancer is the most common cancer found in men and the second deadliest behind lung cancer. But just last week the U.S. Preventive Services Task Force recommended the PSA, a blood test used to detect prostate cancer, should no longer be used. KFOX14 spoke to a local doctor who disagrees with the task force. "Prostate cancer is very common in El Paso and so is breast cancer. Therefore if we have a test, a screening test to find cancer...  

The ViewRay system features a unique combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI) for the treatment of cancer. ViewRay's treatment planning and delivery software received 510(k) premarket notification ...  

Advaxis Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed enrollment of 110 patient in Lm-LLO-E7-15, randomized phase II trial of ADXS-HPV in women with recurrent/refractory cervical ...  

A startling number of women at high-risk for developing breast cancer aren't taking a drug that could help prevent it, and it's because of what doctors call serious but rare side effects. Doctors estimate that up to 95 percent of women who are eligible to ...  

Tokyo, Sept 7, 2006 (JCN) - Takara Bio Inc., a forerunner in cancer treatment, has offered its RetroNectin for the treatment chronic lymphatic leukemia in phase-I clinical trials currently being conducted at the U.S. Memorial Sloan-Kettering Cancer Center (MSKCC).  

mesothelioma cancer doctors and treatment centers and mesothelioma attorneys. Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50294441〈=en Baron & Budd, P.C.Susan Knape, 214-629-0596susan@susanknape.comorAmanda Theaker, 214-991-1051atheaker@baronbudd.com Source: Baron & Budd, P.C.  

Younger patients with colorectal cancer were more likely to present advanced stage tumors at diagnosis and metastasize much sooner, yet had better than or equal survival to patients 50 and older, according to data being presented at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago  

Treatment of early-stage prostate cancer may also improve quality of life (QOL) if patients have previously suffered from obstructive urinary symptoms before undergoing treatment, shows US research. The findings, presented at the American ...  

Cancer researchers have known for well over a century that different tumor types spread only to specific, preferred organs. But no one has been able to determine the mechanisms of organ specific metastasis, the so-called "soil and seed" theory of 1889. New details that could help shed light on this hypothesis have been provided by a team of researchers from Weill Cornell Medical College, Memorial Sloan-Kettering Cancer Center, and their...  

Some men die of complications from surgery to remove the prostate, and many others suffer side effects. Others worry for years they will develop cancer after their tests. But the recommendation is not sitting well with some doctors who still ...  

Professor Daniel Wreschner of Tel Aviv University is developing new antibodies that bind to and kill off cancer cells exclusively. These antibodies have the potential to be used as a more efficient and effective method of delivering chemotherapy drugs directly to their targets.  

The task force that sparked controversy with its breast cancer screening recommendations a few years ago -- and PSA prostate-cancer screening pronouncements last week -- is weighing in on hormone replacement therapy. ...  

In a recent study it was found that Modified Citrus Pectin (MCP) can boost the anti-cancer effects of two poly-botanical formula. It was found that when co-administered with formulas that attack breast and prostate cancer, MCP significantly ...  

While no definitive conclusions can be drawn given the limited sample size, the results suggest that African-American patients with metastatic castrate-resistant prostate cancer benefit from treatment with sipuleucel-T and provide support for ...  

May 29, 2012 (Atlanta, Georgia) — A multicenter study has confirmed the clinical utility of an epigenetic multiplex gene assay (ConfirmMDx, MDxHealth Inc.) in the identification of prostate cancer. The assay correctly identified the presence of cancer in ...  

NORTHVALE, N.J.--(BUSINESS WIRE)--On May 22, the U.S. Preventive Services Task Force, a prominent U.S. government advisory panel, published its definitive recommendation that men of all ages should no longer be screened for prostate cancer by means of the prostate-specific-antigen (PSA) blood test. The Task Force, an independent group of medical experts in prevention and evidence-based medicine, said PSA-screening results in over-diagnosis of...  

A peer reviewed study recently published in the World Journal of Gastroenterology entitled ‘High resolution colonoscopy in bowel cancer screening program improves polyp detection’ [1] highlights the effectiveness of PENTAX’s HD+ endoscopes for polyp ...  

Onyx Pharmaceuticals, Inc. today announced that Bayer HealthCare has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the oral multi-kinase inhibitor regorafenib for the treatment of patients with metastatic colorectal cancer (mCRC).  

Washington, May 27 : Modified Citrus Pectin (MCP), a highly researched natural compound, can boost the anti-cancer effects of two poly-botanical formulas, according to a new study. It was found that when co-administered with formulas that attack breast and ...  

Fairfax, Va. - The American Society for Radiation Oncology (ASTRO) is disappointed with the U.S. Preventive Services Task Force's (USPSTF) final recommendations against the use of prostate-specific antigen (PSA)-based screening for prostate cancer and ...  

These sunscreens were rated the worst based on their low protection against UVA radiation, which causes signs of aging and increased risk of skin cancer. The FDA is requiring new labeling and testing so that sunscreens that claim to be broad spectrum will ...  

The new report features extensive primary research with Russian oncologists as well as a market outlook by drug and class through 2016 and colorectal cancer epidemiology through 2021. About Emerging Markets Reports Decision Resources is the ...  

LONDON: Bald men may be more at risk of developing prostate cancer, a new research has revealed. Researchers found that men who underwent prostate biopsies were more likely to be diagnosed with cancer if they had lost significant amounts of hair.  

Washington, May 27: Modified Citrus Pectin (MCP), a highly researched natural compound, can boost the anti-cancer effects of two poly-botanical formulas, according to a new study. - Indiatalkies.com  

Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter serious pushback from primary care physicians, according to results of a survey by Johns Hopkins investigators...  

SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc., a CLIA-certified laboratory testing company focused on oncology diagnostics, specifically the detection and analysis of circulating tumor cells (CTCs) in cancer patients, announced that with collaborators from Columbia University Medical Center and the MD Anderson Cancer Center, it will present three (3) posters at the Annual Meeting of the American Society for Clinical Oncology (ASCO) being held in...  

Cabazitaxel has been approved since March 2011 in men with metastatic prostate cancer who no longer respond to conventional therapy with hormone blockers and have already been pre-treated with the cytostatic drug docetaxel.  

PRINCETON, N.J., May 29, 2012 (BUSINESS WIRE) -- Bristol-Myers Squibb Company today announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understanding of immuno-oncology. Immuno-oncology focuses on the potential of harnessing the intelligence of the body's own immune system to fight cancer...  

Massage is offered for oncology patients undergoing definitive ... You need JavaScript enabled to view it . Prostate cancer survivors St. Vincent's SWIM Prostate Cancer Survivors Educational Lecture Series and Support Group meets at Elizabeth Pfriem ...  

Background: Most infections with human papillomavirus (HPV) are resolved without clinical intervention, but a minority evolves into chronic lesions of distinct grades, including cervical-uterine cancer. It is known that in most cases the immune system mediates elimination of HPV infection. However, the mechanism of immune evasion leading to HPV ersistence and development of early cervical lesions is not fully understood. The aim of the present...  

Brachytherapy, or internal radiation therapy, has become a staple for cancer treatment and an alternative to external beam radiation. Many hospitals offer low-dose rate brachytherapy, or seed radiation, which involves implanting radioactive ...  

When it comes to making the shot against cervical cancer the national vaccine programme, which means girls between the ages of 12-18 will receive it free, price is the matter. The debate over the price of the vaccine against Human Papillomavirus (HPV), a ...  

"There are always a few suspicious lesions picked up, for example atypical moles, skin cancers such as basal cell carcinoma ... also requires surgical removal. Melanoma can be cured if it is found early and removed. However, if left untreated, melanoma ...  

The panel concluded the number of lives saved did not outweigh the risks of wrong diagnosis, unnecessary biopsies, and harm of harsh treatments that could result on incontinence and impotence “It’s indignant! It’s incredible that they ...  

IsoRay Inc. (NYSE Amex: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced that Discovery Channel has featured the Company's Cesium-131 brachytherapy (internal radiation therapy ...  

Two years ago when Kent Hormann started the Blue Ball Open to raise awareness for prostate cancer, his only intention was to give back to the community and hopefully emulate a fraction of Vera Bradley's success with breast cancer awareness.  

Cancer researchers have known for well over a century that different tumor types spread only to specific, preferred organs. But no one has been able to determine the mechanisms of organ specific metastasis, the so-called "soil and seed" theory of 1889.  

Flexible sigmoidoscopy and colonoscopy are more effective than fecal occult blood testing in diagnosing polyps that may result in colorectal cancer. The risk of colorectal cancer is reduced by the removal of pre-cancerous polyps by sigmoidoscopy.  

New website, Celebrating-Survivorship.com, gives cancer patients, survivors and supporters a place to share stories and information to improve quality of life CEDAR RAPIDS, Iowa--(BUSINESS WIRE)-- There is more to celebrate this June 3rd, National Cancer ...  

Advaxis, Inc., (ADXS.OB), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced today that it has completed enrollment in Lm-LLO-E7-15, the 110 patient, randomized Phase 2 trial of ADXS-HPV ...  

The Royal College of Surgeons in Ireland (RCSI) is leading an international team of scientists on a major research study which aims to predict colorectal cancer patients' response to the 'angiogenesis inhibitor' class of anti-cancer drug which prevents growth of tumour blood vessels. The study will facilitate a more focused therapeutic approach thus limiting side-effects in patients.  

VACCINATION complements Pap smears in the prevention of cervical cancer ('Cervical cancer: Be careful about promoting vaccination' by Mr Edmund Leong; last Saturday). Imagine an efficient police force that regularly sends patrol cars to ...  

ARLINGTON HEIGHTS, Ill., May 29, 2012 (GLOBE NEWSWIRE) -- The American Society of Colon and Rectal Surgeons (ASCRS) has given its 2012 David Jagelman, MD, Award for Advocacy in Colorectal Cancer to Andrew Spiegel, Chief Executive Officer of the Colon Cancer Alliance (CCA) and one of the world's leading advocates on behalf of colorectal cancer patients. The award will be presented during the Society's Annual Meeting in San Antonio, TX, on...  

Background: Controversy exists as to the ability of human gammaherpesviruses to cause or exacerbate breast cancer disease in patients. The difficulty in conducting definitive human studies can be overcome by investigating developing breast cancer in a mouse model. In this study, we utilized mice latently infected with murine gammaherpesvirus 68 (HV-68) to question whether such a viral burden could exacerbate metastatic breast cancer disease...  

A prostate cancer protein has been identified that could lead to new diagnostic tests and treatments. The protein is made by the PRKCZ gene, which has previously been shown to play a role in aggressive prostate cancer. Scientists found that one version of ...  

Factors influencing early life non-Hodgkin lymphoma (NHL) incidence include family characteristics, high fetal growth, older maternal age, low birth order, and male gender, according to a study published in the Journal of the National Cancer Institute. Over the last 50 years, NHL incidence increased substantially, although the overall incidence started to stabilize in the 1990s, at least among adults. But incidence has continued to climb in...  

TIMENew prostate cancer screening guidelines face a tough sell, study suggestsScience Daily (press release)ScienceDaily (May 26, 2012) — Recent recommendations from the US Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter serious ...PSA Screening Controversy: FAQWebMDStop prostate screening with PSA test? Not all doctors...  

Advanced ovarian cancer is treated with cytoreductive surgery and combination platinum- and taxane-based chemotherapy. Although most patients have acute clinical response to this strategy, the disease ultimately recurs. In this work we questioned whether ...  

On Thursday, May 24, 2012, the Mesothelioma Applied Research Foundation (Meso Foundation) hosted Dr. Raffit Hassan from the National Cancer Institute (NCI) in an interview about his most recent clinical trial for pleural and peritoneal mesothelioma patients.  

Older maternal age, low birth order, male gender, family characteristics, and high fetal growth are all factors that increase the risk of developing early life non-Hodgkin lymphoma (NHL), say researchers. According to the study, published in the Journal of National Cancer Institute, the incidence of NHL has increased significantly over the last 5 decades. Although the overall incidence began to stabilize among adults, it has continued growing...  

Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston. CHICAGO -- Among women with primary epithelial ovarian cancer, the time to recurrence was no different between obese and non-obese ...  

Prostate cancer generally grows slowly and initially remains confined to the prostate gland, where it may not cause serious harm. Although some types of prostate cancer grow slowly and may need minimal or no treatment, other types are aggressive ...  

Bald men may be more at risk of developing prostate cancer, according to new research. Scientists found men who underwent prostate biopsies were more likely to be diagnosed with cancer if they had lost significant amounts of hair. The reasons why are not ...  

The Pennsylvania Supreme Court has rejected a theory put forth in many mesothelioma lawsuits, which suggests that even the smallest exposure to asbestos, involving one fiber or one breath, can cause the rare and fatal form of cancer. In a unanimous opinion ...  

Inhaling asbestos fibres can cause lung cancer or mesothelioma, a cancer of the lining of the chest and the abdominal cavity. There is also convincing evidence of asbestos exposure leading to laryngeal and ovarian cancer. She said that when asbestos starts ...  

Background: Saffron extract, a natural product, has been shown to induce apoptosis in several tumor cell lines. Nevertheless, the p53-dependency of saffron's mechanism of action in colon cancer remains unexplored. Methods: In order to examine saffron's anti-proliferative and pro-apoptotic effects in colorectal cancer cells, we treated two p53 isogenic HCT116 cell lines (HCT wildtype and HCT p53-/-) with different doses of the drug and analyzed...  

Jo’s Cervical Cancer Trust (or Jo’s Trust) is the only UK charity dedicated to women and their families who have been affected by cervical cancer and cervical abnormalities. PRLog (Press Release) - May 28, 2012 - Jo’s Cervical Cancer Trust (or Jo’s ...  

Recent recommendations from the US Preventive Services Task Force advising elimination of routine prostate-specific antigen screening for prostate cancer in healthy men are likely to encounter serious pushback from primary care physicians, according to results of a new survey.  

Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib kill leukemia cells much more effectively when combined than when the drugs are administered individually. Recently published in the journal Blood, the results of a study led by Steven Grant, M.D...  

Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter serious pushback from primary care physicians, according to results of a survey by Johns Hopkins investigators.  

A team of scientists has developed a promising new strategy for "reactivating" genes that cause cancer tumors to shrink and die. The researchers hope that their discovery will aid in the development of an innovative anti-cancer drug that effectively targets unhealthy, cancerous tissue without damaging healthy, non-cancerous tissue and vital organs. The research will be published in the Journal of Biological Chemistry...  

Elderly patients with inoperable non-small-cell lung cancer (NSCLC) who take a daily dose of carboplatin (a chemotherapy drug), in addition to radiotherapy, live significantly longer than those who receive radiotherapy alone, say Japanese researchers. The study is published Online First in The Lancet Oncology. Shinji Atagi from Kinki-chuo Chest Medical Center, Osaka, Japan, said: "[Until now] evidence supporting standard treatment with...  

Background: Elderly patients are more vulnerable to toxicity from chemotherapy. Activating epidermal growth factor receptor (EGFR) mutations in non-small-cell lung cancer (NSCLC) are associated with enhanced response to EGFR tyrosine-kinase inhibitors. We studied patients with advanced NSCLC for whom treatment was customized based on EGFR mutation status. Methods: We screened 57 chemotherapy-naive patients with histologically or cytologically...  

Flexible sigmoidoscopy, a screening test for colorectal cancer that is less invasive and has fewer side effects than colonoscopy, is effective in reducing the rates of new cases and deaths due to colorectal cancer, according to research sponsored by the National Cancer Institute, part of the National Institutes of Health. In a study that spanned almost 20 years, researchers found that overall colorectal cancer mortality (deaths) was reduced by...  

Researchers from Memorial Sloan-Kettering Cancer Center have begun testing for three new genetic targets and found that together they occur in approximately 50 percent of patients with squamous cell carcinomas of the lung, which affects 40,000 Americans each year. Initial findings of the research will be presented on June 4 at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.  

Folic acid fortification of foods may reduce the incidence of the most common type of kidney cancer and a type of brain tumors in children, finds a new study by Kimberly J. Johnson, PhD, assistant professor at the Brown School at Washington University in St. Louis, and Amy Linabery, PhD, postdoctoral fellow at the University of Minnesota. Incidence reductions were found for Wilms' tumor, a type of kidney cancer, and primitive neuroectodermal...  

Recent Progress in the Management of Metastatic Breast Cancer, a Clinical ...MedPage TodayJoining me today is Dr. Edith Perez of the Mayo Clinic in Jacksonville, Fla., and we will be discussing various aspects of metastatic breast cancer in the next few minutes. I'd like to start off by asking if you could sort of define the problem.  

Here are all the videos I have made for oncolex.org of diagnosis and treatment for primary liver cancer, now with English voice overs. Oncolex is a cancer resource for health care professionals made by Oslo University Hospital in collaboration with M.D. Anderson Cancer Center. Warning: All these videos show actual examinations and surgery. Radio Frequency Ablation (RFA) Destruction of a liver tumor using high frequency alternating current...  

Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston. SAN DIEGO -- Type 2 diabetes patients may need to be screened earlier for colorectal cancer, researchers said here. In a single-center ...  

By simply shining a tiny light within the small intestine, close to that organ's junction with the pancreas, physicians at Mayo Clinic's campus in Florida have been able to detect pancreatic cancer 100 percent of the time in a small study. The light, attached to a probe, measures changes in cells and blood vessels in the small intestine produced by a growing cancer in the adjoining pancreas. This minimally invasive technique, called...  

Women with advanced breast cancer who have higher levels of fitness during treatment tend to live longer than women with lower levels of fitness during treatment, new research finds. Treatments for breast cancer can weaken women's heart and lung function ...  

CHICAGO -- The poly-ADP ribose polymerase (PARP) inhibitor olaparib turned in another good showing in ovarian cancer, boosting progression-free survival by nearly 3 months relative to chemotherapy alone, researchers said. In a 162-patient phase ...  

Stand Up To Cancer and Safeway Foundation have teamed up with Angie Harmon to raise awareness and funds in the fight against prostate cancer. Prostate cancer currently affects more than two million American men and remains the second-leading cause of cancer death for men in the US. 1 in 6 men will be diagnosed with prostate cancer in his lifetime. Ms. Harmon, who will return to primetime television in the summer of 2012 in the third season of...  

We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until now, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins. From metastasis in bladder cancer, to seminal vessel involvement in prostate cancer, to shortened survival in squamous cell carcinoma, a study published...  

The 25th annual National Cancer Survivors Day is set for Sunday, June 3rd and the Omaha Cancer Survivors Day Committee will stage a celebration at Cancer Survivors Park, 107th and Pacific. The free event from 11:30am to 2:30pm will feature guest ...  

and Leonard Lance (R-NJ) and in the Senate by Senator Sheldon Whitehouse (D-RI), will ensure that the National Cancer Institute (NCI) develops a long-term comprehensive strategic plan for developing early diagnostics and treatment options that ...  

and Leonard Lance (R-NJ) and in the Senate by Senator Sheldon Whitehouse (D-RI), will ensure that the National Cancer Institute (NCI) develops a long-term comprehensive strategic plan for developing early diagnostics and treatment options that will ...  

Newswise — Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter serious pushback from primary ...  

A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to ...  

Millions of American males are certain to have a new conversation with their personal physicians in the wake of Monday's news that PSA tests, commonly used to detect prostate cancer, do more harm than good. New guidelines from the U.S. Preventive Services Task Force says doctors should avoid using PSA tests to screen healthy men.… [ Read more ] [ Subscribe to the comments on this story ]  

MINYANVILLE ORIGINAL In yesterday's article (see What You Must Know Before Investing in Prostate Cancer Stocks) I outlined how prostate cancer patients are treated. Urologists "own" the patient until the point they are broadly metastatic and symptomatic. Up until that point oncologists typically are not consulted. Understanding this urologist/oncologist patient ownership battle is critical to making smart investments in the prostate cancer...  

(Medical Xpress) -- A team of scientists has developed a promising new strategy for "reactivating" genes that cause cancer tumors to shrink and die. The researchers hope that their discovery will aid in the development of an innovative anti-cancer drug that effectively targets unhealthy, cancerous tissue without damaging healthy, non-cancerous tissue and vital organs. The research will be published in the Journal of Biological Chemistry.  

Background: Breast cancer survivors, particularly those treated with chemotherapy, are at significantly increased risk for long-term cognitive and neurobiologic impairments. These deficits tend to involve skills that are subserved by distributed brain networks. Additionally, neuroimaging studies have shown a diffuse pattern of brain structure changes in chemotherapy-treated breast cancer survivors that might impact large-scale brain networks...  

Re: “Test did more harm,” May 23 Virginia A. Moyer column. Virginia A. Moyer’s excellent column on prostate screening gives plenty of food for thought. It may have been a bit too harsh on the prostate-specific antigen (PSA) test — “a recommendation against screening men of any age for prostate cancer using the PSA test.” [...]  

Following a period for public comment, the United States Preventive Services Task Force (USPSTF) released its final recommendation for prostate cancer screening. The Task Force now recommends against PSA-based screening for all men, regardless of age. The final recommendations are being published early online in the May 22 issue of Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP). The Task Force...  

The Purple Stride 5K walk and 10K timed run to raise money for pancreatic cancer research is scheduled for Sept. 22 at RCTC (time yet to be announced). A decade ago, Sharon Nagel traveled a long road to healing after surgery and complications.  

For these patients, we can consider a policy of active surveillance, watching them closely to ensure their cancer does not transform into more aggressive disease. But we cannot determine which patients need treatment and which can be watched if ...  

endoscopy and gastrointestinal surgery. Patient Satisfaction and Preferences: Colonoscopy or Computed Tomography Colonography for Colorectal Cancer Screening (Abstract #445)Patients in a recent study were more satisfied with colonoscopy than ...  

The American Society for Radiation Oncology said it was "disappointed" by a U.S. Preventive Services Task Force panel's recommendation that healthy men avoid prostate-specific antigen screenings for prostate cancer, saying a "blanket no-testing ...  

Cancer screening tests — including the prostate-specific antigen (PSA) test to look for signs of prostate cancer — can be a good idea. Prostate cancer screening can help identify cancer early on, when treatment is most effective. And a normal PSA test ...  

Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter serious pushback from primary care physicians, according to results of a survey by Johns Hopkins investigators.  

Dr. Bruce Cheson previews studies to be presented at ASCO® 2012 that will change or confirm therapies in follicular lymphoma, Hodgkin lymphoma, myeloma, and more. Medscape Hematology-Oncology  

The decision on which treatment is the best for an individual hinges on ... Usually lymph nodes near the testicle are removed as part of the surgery to gauge any spread of the cancer. Ultrasound exams of the abdomen, pelvis and chest also ...  

ATLANTA, May 21, 2012 /PRNewswire/ -- The American Urological Association (AUA) today released the following statement in response to the U.S. Preventive Services Task Force (USPSTF) recommendations on the use of the prostate-specific antigen (PSA) test. The statement is...  

I start my first round of chemo this coming Friday. I have read the info from the oncologist and feel fairly well prepared ( I am sure you chemo veteran's are thinking "sure you are"). I have a question, though: I am thinking of getting either a juicer or ...  

A controversial new report that recommends against routine prostate screenings has sparked a wide debate among doctors, cancer survivors and patients. The United States Preventive Services Task Force issued their final report on Monday, recommending against prostate-specific antigen (PSA) screening for prostate cancer for men of any age. The reason? Very few men actually need [...]  

The data on PSA testing to detect prostate cancer has long been shaky — so much so that the discoverer of PSA (or prostate-specific antigen, an enzyme made by the prostate) himself decried the test two years ago as “hardly more effective ...  

WASHINGTON -  After lung cancer, prostate cancer is the most prevalent killer of men in the United States. So when the U.S. Preventive Services Task Force (USPSTF) recommended that men stop having a test that can tell if they have prostate cancer, it stirred up controversy in the medical community. For years, men over the age of 40 were told to get a simple blood test to see if they have prostate cancer. But the rationale behind the new...  

Description: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for prostate cancer. Methods: The USPSTF reviewed new evidence on the benefits and harms of prostate-specific antigen (PSA)–based screening for prostate cancer, as well as the benefits and harms of treatment of localized prostate cancer. Recommendation: The USPSTF recommends against PSA-based screening for prostate cancer (grade...  

Flexible sigmoidoscopy, a screening test for colorectal cancer that is less invasive and has fewer side effects than colonoscopy, is effective in reducing the rates of new cases and deaths from colorectal cancer, according to research sponsored by the National Cancer Institute, part of the National Institutes of Health.  

In a highly anticipated move sure to unleash heated debate, a prominent U.S. government advisory panel is recommending that men of all ages no longer be screened for prostate cancer by undergoing the prostate-specific antigen (PSA) blood test.  

Bridgeport, CT: A $2.4 million settlement has just been awarded in an asbestos mesothelioma lawsuit brought by the family of Hannibal “Scottie” Saldibar, a tile setter from New Haven, who died after contracting the asbestos-related cancer. Saldibar ...  

NASHUA – Manuela St. Germain had no idea that she had two forms of breast cancer until her annual mammogram scan showed lumps deeply hidden in her tissue. Around September, St. Germain was diagnosed with lobular carcinoma in situ, more commonly known as LCIS, and ductal carcinoma in situ, or DCIS.  

MONDAY, May 21 (HealthDay News) -- In a highly anticipated move sure to unleash heated debate, a prominent U.S. government advisory panel is recommending that men of all ages no longer be screened for prostate cancer by undergoing the prostate-specific antigen (PSA) blood test.  

From metastasis in bladder cancer, to seminal vessel involvement in prostate cancer, to shortened survival in squamous cell carcinoma, a study published this week in the journal Cancer Research shows that proteins RalA and RalB are associated ...  

As a prostate-cancer survivor, I took particular note of the U.S. Preventive Services Task Force's recommendation against the use of prostate-specific antigen screening as an indicator of prostate cancer risk. This government panel impressively ...  

Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib kill leukemia cells much more effectively when combined than when the drugs are administered individually.  

"I have tingling and numbness in my hands and feet, due to chemotherapy for breast and ovarian cancer ... so they can assess it. • Follow instructions regarding rest and delays in treatment. • Be active in decisions regarding treatment versus quality ...  

A new prostate cancer treatment has been rejected for use in Ireland. Zytiga, which has been dubbed a `wonder drug', can extend the lives of late-stage prostate cancer sufferers. According to a report in the Sunday Business Post, the drug was approved for ...  

Hello. I am Dr. Maurie Markman from Cancer Treatment Centers of America in Philadelphia. I want to comment on the upcoming American Society of Clinical Oncology (ASCO®) meeting, particularly the gynecologic cancer session. The abstracts are ...  

ATLANTA – A baseline prostate-specific antigen (PSA) value of less than 1 ng/mL predicted a low risk of prostate cancer over the next 15 years in men younger than 50, none of whom developed intermediate- or high-risk cancer, data from a ...  

NEW YORK (Reuters) - A task force advising the U.S. government on Monday recommended against routine use of the prostate-cancer screening test called PSA, or prostate specific antigen, for lack of a discernible health benefit. Like a draft ...  

The disease is terminal, but aggressive therapy can prolong the lives of patients who are diagnosed early. The New York mesothelioma lawyers of Belluck & Fox, LLP, have a history of providing legal assistance to those who have suffered mesothelioma due to ...  

Despite recent recommendations from the US Preventive Services Task Force, many people simply don't believe that the prostate-specific antigen test is ineffective. Even faced with overwhelming evidence, many activists and medical professionals are clamoring for men to continue receiving their annual PSA test. Why the disconnect? A new article examines the reasons why people are so reluctant to give up the PSA test.  

The men completed questionnaires on the severity of their lower urinary tract symptoms, their age and whether they took medications used to treat enlarged prostate (benign prostatic hyperplasia). Four of the genetic variants were associated with severity ...  

The AAFP is recommending against performing prostate-specific antigen (PSA)-based screening for prostate cancer in asymptomatic men, a position that is in line with a final recommendation from the U.S. Preventive Services Task Force that was published May 22 in the Annals of Internal Medicine. The recommendation applies to asymptomatic men in the general U.S. population, regardless of age, but does not include the use of the PSA test for...  

Photo: Microsoft The PSA is a simple blood test that measures levels of PSA that may determine prostate cancer. A positive result from the PSA screening can lead to unnecessary medical procedures. The PSA is a simple blood test that measures ...  

Sun exposure is the main cause of malignant melanoma and non-melanoma skin cancer. Cancer Research UK have found that ’In 2010, 2749 people in the UK died from malignant melanoma and non-melanoma skin cancer, with such cases in Britain quadrupling over ...  

By simply shining a tiny light within the small intestine, close to that organ’s junction with the pancreas, physicians have been able to detect pancreatic cancer 100 percent of the time in a small study. The light, attached to a probe, measures changes in cells and blood vessels in the small intestine produced by a growing cancer in the adjoining pancreas.  

Doctors should no longer offer the PSA prostate cancer screening test to healthy men, because they're more likely to be harmed by the blood draw - and the chain of medical interventions that often follows - than be helped, according to government advisory panel's final report.  

WEDNESDAY, May 23 (HealthDay News) -- Getting chemotherapy before breast cancer surgery can mean the difference between ... chemotherapy before their surgery are more likely to be able to have breast-conserving surgery than women given chemo after their ...  

Methodist Hospital's Surgical and Oncology Unit will host a community celebration in honor of National Cancer Survivors Day on Sunday, June 3, from 2 to 4 p.m. in Classroom 1 located on the Ground Floor ... be given the opportunity to share ...  

major cancer and health organizations have not advocated for routine prostate-cancer screening in men the same way they recommend mammography for breast-cancer screening in older women. Instead, experts have advised men to begin discussing their ...  

Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston. CHICAGO -- A promising treatment approach for metastatic colorectal cancer can be used safely in patients previously treated with ...  

By simply shining a tiny light within the small intestine, close to that organ's junction with the pancreas, physicians at Mayo Clinic in Florida have been able to detect pancreatic cancer 100 percent of the time in a small study. The light, attached to a probe, measures changes in cells and blood vessels in the small intestine produced by a growing cancer in the adjoining pancreas.  

In a controversial decision, the U.S. Preventive Services Task Force is recommending that healthy men not undergo the prostate-specific antigen (PSA) test. That could lead to an increase in cancer, says Dr. Carl Rossi Jr., a Scripps prostate cancer expert.  

Background: Renal cell carcinoma or RCC is one of the common and most lethal urological cancers, with 40% of the patients succumbing to death because of metastatic progression of the disease. Treatment of metastatic RCC remains highly challenging because of its resistance to chemotherapy as well as radiotherapy, besides surgical resection. Whereas RCC comprises tumors with differing histological types, clear cell RCC remains the most common. A...  

Men should not get routinely screened for prostate cancer using the PSA test, a government panel recommends. The panel finds that there is little evidence that testing for PSA, or prostate specific antigen, saves men’s lives, while causing too ...  

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year ...  

In a widely anticipated move, the USPSTF officially recommended against prostate cancer screening in healthy men. Case closed, right? Hardly. The prostate cancer screening debate has been raging for the past decade. Increasing amounts of evidence show that screening does not save lives, and increase the risk of complications like impotence and urinary incontinence that [...]  

A promising new strategy for "reactivating" genes that cause cancer tumors to shrink and die has now been developed. The discovery may aid the development of an innovative anti-cancer drug that effectively targets unhealthy, cancerous tissue without damaging healthy, non-cancerous tissue and vital organs.  

Radiation oncologist Dr. Oh-Hoon Kwon, of Fox Valley Radiation Oncology, has joined the Edward Cancer Center. Kwon, a native of Palatine, is board certified in radiation oncology and is a member of the American Society for Radiation Oncology. He earned his ...  

BOSTON--(BUSINESS WIRE)--On Monday, May 21, 2012 the United States Preventive Services Task Force (USPSTF) issued their final recommendation on the PSA prostate cancer screening test, recommending against routine PSA exams for men of any age. In light of this recommendation, Health Dialog made our decision aid on prostate cancer testing publicly available, as we realize that men and their families will have lots of questions about the...  

When Steven Truscott went to see his doctor last spring and took a blood test to screen for prostate-specific antigen (PSA), he had to pay for it himself. But now that he is diagnosed with cancer, OHIP pays for any ongoing PSA tests. “That’s stupid ...  

Re "Panel: End routine prostate cancer screening" (Page A1, May 22): Unfortunately, the U.S. Preventative Services Task force persists in its erroneous conclusion that prostate cancer screening is harmful. Despite abundant evidence that the task ...  

The United States Preventive Services Task Force today has made a final recommendation on prostate cancer screening: not needed, regardless of age. Specifically, the Task Force found that prostate-specific antigen, or PSA, blood tests, the traditional test used to detect evidence of prostate cancer, do more harm than good.  

Xcovery, a developer of next-generation targeted therapeutics for cancer, today announced that investigators will present data from its Phase 1 clinical study which evaluated X-82, an oral VEGFR tyrosine kinase inhibitor (TKI), in patients with advanced solid tumors.  

May is Melanoma Skin Cancer Awareness MonthPatch.comAs a registered nurse and the former ranking member of the New York State Assembly Health Committee, I would like to share with you some important information about skin cancer from the American Cancer Society and the National Cancer Institute.Skin cancer survivor warns against tanning13abc Action Newsall 2 news articles »  

Minimally invasive retroperitoneal lymph node dissection in cases of testicular cancer produces excellent outcomes and reduces length of stay, according to a nationwide study conducted by urologists at the University of California, San Diego.  

"Without that PSA test, I'm probably dead. I don't know how somebody can say that it's not a worthwhile test," said Johner, who underwent surgery to remove his cancerous prostate gland a number of years ago. Earlier this week, the U.S. Preventative ...  

A controversial new report that recommends against routine prostate screenings has sparked a wide debate among doctors, cancer survivors and patients. The United States Preventive Services Task Force issued their final report on Monday, recommending against prostate-specific antigen (PSA) screening for prostate cancer for men of any age. The reason? Very few men actually need treatment to survive and the side effects from prostate cancer...  

Selenium and/or Vitamin E Do Not Prevent Bladder CancerDoctors LoungeNeither selenium nor vitamin E alone or used in combination appears to prevent bladder cancer in men, according to a study published in the June issue of The Journal of Urology. FRIDAY, May 25 (HealthDay News) -- Neither selenium nor vitamin E alone or ...  

(CBS News) A top panel of health experts called the U.S. Preventive Services Task Force says that men should no longer get routine prostate-specific antigen (PSA) tests to screen for prostate cancer. The reason, it says, is that the tests may ...  

Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib kill leukemia cells much ...  

This is a continuation of my previous article on biotechnology stocks to watch ahead of ASCO 2012 ... Its product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase (c-Met). C-Met is a target for cancer therapy, based ...  

Mesothelioma is a rare form of cancer caused by exposure to asbestos and breathing asbestos fibers. It is a very serious disease, which is often at a very advanced stage when a diagnosis is made. Asbestos lawsuits have been filed by thousands of ...  

In particular, if the taste or the sheer volume of bowel prep causes a patient to drink less of it, it could prevent adequate cleansing of the colon, making it harder for the physician to detect polyps. "If the bowel prep experience is intolerable for the ...  

This week let us spotlight an upcoming free public celebration, National Cancer Survivors Day, along with a locally based organization that is working to encourage national awareness about ovarian cancer and to promote education about the ...  

Richmond, Va. – (May 22, 2012) – Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib ...  

(CNN)-- Should men be routinely screened for prostate cancer? This question has been asked ever since the prostate specific antigen test, or PSA, became widely available more than two decades ago. Central to this question is another question ...  

Motzer, MD, of Memorial Sloan-Kettering Cancer Center in New York City, and colleagues. In an abstract published ahead of the annual meeting of the American Society of Clinical Oncology here, the researchers also reported an objective response ...  

The final recommendation for prostate cancer screening has been released by the United States Preventive Services Task Force (USPSTF). The Task Force now recommends against PSA-based screening for all men, regardless of age. The final ...  

Amid the many messages you may be hearing about screening for prostate cancer, I hope these stand out most prominently: Science finds that there is at best a small potential benefit from prostate cancer screening, and there are substantial known ...  

Mesothelioma cancer, which is found in the lining of the chest and lungs, is only known to occur as a result of exposure to asbestos. The disease has a very long latency period and is often not discovered until decades after exposure, leading to a limited ...  

Too much PSA, or prostate-specific antigen, in the blood only sometimes signals prostate cancer is developing. However, it can also mean a benign enlarged prostate or an infection and a further biopsy is needed. Most men will get prostate cancer if they ...  

May 21, 2012 — It's final. The US Preventive Services Task Force (USPSTF) now officially recommends against routine prostate-specific antigen (PSA)–based prostate cancer screening for healthy men, regardless of age. Today the Task Force ...  

Magnetic resonance imaging (MRI) scans may provide an early measure of how women will respond to chemotherapy for breast cancer, according to a new study published in the journal Radiology. Women with breast cancer who undergo pre-surgery ...  

A government task force is recommending that men should stop receiving a routine blood test to check for prostate cancer because the test does more harm than good. At best, the prostate specific antigen (PSA) blood test will save one life out of ...  

"We don't disagree that there are harms -- there's anxiety and side-effects from treatment -- but we think that they are ... While acknowledging the test is far from perfect, "there really is no other way out there to detect prostate cancer when it's ...  

May 23, 2012 (Atlanta, Georgia) — The 2011 US Preventive Services Task Force (USPSTF) draft policy for prostate cancer screening, which became final this week, might result in significant costs related to disease burden and treatment, according to ...  

NEW YORK, May 21 (Reuters) - A task force advising the U.S. government on Monday recommended against routine use of the prostate-cancer screening test called PSA, or prostate specific antigen, for lack of a discernible health benefit. Like a draft proposal ...  

My mother in law was diagnosed with stage four spindle cell carcinoma (originating in the gall bladder) after having her gall bladder removed. She has tumors all through her abdomen. Some of them are even visible on the outside. My husband says that one ...  

In a startling reversal of years of pressing healthy men to get routine PSA prostate tests, U.S. health officials now say these tests do more harm than good. What’s more, the United States Preventive Services Task Force (USPSTF) said they aren’t recommending the tests for men of any age. The task force is basing its new stance on research that shows that only one out of every 1000 men who are screened would actually benefit from the exam...  

The Department of Health is to test plans to replace smear tests as the primary screening method for cervical cancer, after its advisors said HPV testing may ‘better indicate which women are at risk'. The development comes after studies showed using HPV ...  

Science jobs from CNRS (Centre national de la recherche scientifique): A 3 years postdoctoral position is currently available in 2012 in the team "tyrosine kinase signalling in human cancer" of the Macromolecular Biochemistry Research Center ...  

A routine endoscopy can detect cancer in the pancreas in the nearby adjacent small intestine due to cancer's 'field effect' JACKSONVILLE, Fla. — By simply shining a tiny light within the small intestine, close to that organ's junction with the pancreas ...